Mesenchymal stem cells for amyotrophic lateral sclerosis

The purpose of this dose-escalation study was to determine the safety of intraspinal delivery of adipose-derived mesenchymal stem cells (MSCs) to the cerebral spinal fluid of patients with amyotrophic lateral sclerosis.